scholarly journals Long term follow up of spinal trabecular bone mineral density in women with non-steroid treated rheumatoid arthritis.

1994 ◽  
Vol 53 (2) ◽  
pp. 149-149 ◽  
Author(s):  
A M Cooper ◽  
M M O'Sullivan ◽  
D Clements ◽  
J E Compston ◽  
W D Evans ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Bone Mineral Density ◽  
Trabecular Bone ◽  
Bone Mineral ◽  
Mineral Density ◽  
Trabecular Bone Mineral Density ◽  
Long Term Follow Up

Bone mineral density after renal transplantation: long-term follow-up

1999 ◽  
Vol 31 (6) ◽  
pp. 2322-2323 ◽  
Author(s):  
A Moreno ◽  
J.V Torregrosa ◽  
F Pons ◽  
J.M Campistol ◽  
M.J Martı́nez de Osaba ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Renal Transplantation ◽  
Bone Mineral ◽  
Mineral Density ◽  
Long Term Follow Up

scholarly journals Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up

2016 ◽  
pp. jc.2016-3292 ◽  
Author(s):  
Himika Chawla ◽  
Soma Saha ◽  
Devasenathipathy Kandaswamy ◽  
Raju Sharma ◽  
Vishnubhatla Sreenivas ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Vertebral Fractures ◽  
Mineral Density ◽  
Long Term Follow Up

Long-term follow-up of bone mineral density in Addison's disease

2003 ◽  
Vol 58 (5) ◽  
pp. 617-620 ◽  
Author(s):  
Esteban Jódar ◽  
María Pilar Ruiz Valdepeñas ◽  
Guillermo Martinez ◽  
Antonino Jara ◽  
Federico Hawkins
Keyword(s):  
Bone Mineral Density ◽  
Bone Mineral ◽  
Addison’S Disease ◽  
Addison's Disease ◽  
Mineral Density ◽  
Long Term Follow Up

Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones

1998 ◽  
Vol 48 (3) ◽  
pp. 347-354 ◽  
Author(s):  
Paul Van Kesteren ◽  
Paul Lips ◽  
Louis J. G. Gooren ◽  
Henk Asscheman ◽  
Jos Megens
Keyword(s):  
Bone Mineral Density ◽  
Bone Metabolism ◽  
Sex Hormones ◽  
Bone Mineral ◽  
Mineral Density ◽  
Long Term Follow Up

Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex

1996 ◽  
Vol 6 (S1) ◽  
pp. 277-277
Author(s):  
P. J. M. van Kesteren ◽  
P. Lips ◽  
H. Asscheman ◽  
J. A. J. Megens ◽  
L. J. G. Gooren
Keyword(s):  
Bone Mineral Density ◽  
Bone Metabolism ◽  
Bone Mineral ◽  
Mineral Density ◽  
Long Term Follow Up

scholarly journals Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes

2020 ◽  
Vol 11 ◽  
pp. 204062232098151
Author(s):  
Chung-Yuan Hsu ◽  
Jia-Feng Chen ◽  
Yu-Jih Su ◽  
Ying-Chou Chen ◽  
Han-Ming Lai ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Bone Mineral Density ◽  
Bone Loss ◽  
Disease Activity ◽  
Bone Mineral ◽  
Osteoporosis Treatment ◽  
High Disease Activity ◽  
Mineral Density

Background: Rheumatoid arthritis (RA) is associated with poor bone mineral density (BMD). We designed the current study owing to the lack of long-term prospective studies regarding whether a high disease activity leads to increased bone loss. Methods: We have continually enrolled patients with RA. According to the average disease activity score in 28 joints based on the erythrocyte sedimentation rate (DAS28-ESR) during follow-up, the patients were classified into remission, low disease activity, and moderate or high disease activity groups. Patients were examined with dual-energy X-ray absorptiometry at baseline and after 3 years of follow-up. BMD changes were compared among the groups. Results: We have studied 477 patients. Overall BMD was significantly reduced from baseline to the 3-year follow-up ( p < 0.05). After stratifying according to the time-averaged DAS28-ESR levels and use of anti-osteoporosis treatment (AOT), the BMD values of the femur and spine significantly increased in patients in the remission group with AOT. The BMD changes of different DAS28-ESR patients were further compared using the generalized estimation equation model. For the patients on AOT, the negative change in femoral BMD values of the moderate or high activity group was significant when compared with the remission group with positive BMD changes (regression coefficient, –0.038; 95% confidence interval, –0.055 to –0.021). Conclusion: For RA patients, if remission is achieved, AOT can better improve BMD, especially in the femur. In addition, moderate or high disease activity will lead to significant bone loss; therefore, disease activity must be actively controlled.

scholarly journals The Long-Term Effects of Growth Hormone Replacement on Bone Mineral Density and Trabecular Bone Score: Results of the 10-Year Prospective Follow-up

2021 ◽  
pp. S61-S68
Author(s):  
P. Vaňuga ◽  
M. Kužma ◽  
D. Stojkovičová ◽  
J. Smaha ◽  
P. Jackuliak ◽  
...  
Keyword(s):  
Bone Mineral Density ◽  
Growth Hormone ◽  
Trabecular Bone ◽  
Replacement Therapy ◽  
Bone Mineral ◽  
Trabecular Bone Score ◽  
Mineral Density ◽  
Gh Replacement

There are only few studies concerning about long-term effect of growth hormone (GH) replacement therapy on bone mineral density and bone microstructure. To assess effect of GH replacement therapy on bone mineral density (BMD) and trabecular bone score (TBS) in adult GH deficient (AGHD) subjects over period of 10 years. From 2005 to 2018, a prospective study of AGHD patients was conducted in national referral center for treatment of GHD. All patients received subcutaneous recombinant human GH in an IGF 1-normalizing regimen once a day. Lumbar spine (L-spine) and total hip (TH) BMD using Hologic densitometers were measured at baseline and every two years during treatment with rhGH. TBS was derived from L1-L4 DXA using iNsight® software (Medimaps, France) at each time point. Periods of measurement were baseline, year 2; 4; 6; 8 and 10. In total, 63 patients (38 males, 25 females, mean age 25.1±16 years) were included in the study. After 10 years of GH treatment, IGF-1 significantly increased (~35 %), with greatest increase at year 2. During 10-year follow-up, L-spine BMD increased approximately of 7 % (NS). TH BMD increase of 11 % during follow-up (p=0.0003). The greatest increment of BMD was achieved at year 6 on both sites, L-spine (+6 %) and TH BMD (+13 %) (p<0.05). There was no significant change of TBS during whole follow-up. In this study, sustaining positive effect of GH replacement therapy on bone density in subjects with adult GH deficiency over 10 years of follow-up was observed. The study did not show effect on TBS, as indirect measure of trabecular bone microarchitecture.

Sign in / Sign up

Export Citation Format

Share Document